CIK: 0001842545 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $534,848 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IQV | IQVIA HLDGS INC | 219,495 | $49,336 | 9.2% | $206.17 | -2.6% | COM | 46266C105 |
| ICLR | ICON PLC | 186,200 | $46,587 | 8.7% | $204.83 | +3.7% | SHS | G4705A100 |
| DHR | DANAHER CORPORATION | 172,085 | $41,300 | 7.7% | $208.76 | 0.0% | COM | 235851102 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 170,838 | $37,712 | 7.1% | $176.57 | +25.4% | COM | 91307C102 |
| ILMN | ILLUMINA INC | 165,300 | $30,992 | 5.8% | $221.48 | -8.6% | COM | 452327109 |
| ISRG | INTUITIVE SURGICAL INC | 87,290 | $29,848 | 5.6% | $230.55 | +31.2% | COM NEW | 46120E602 |
| NTRA | NATERA INC | 595,694 | $28,986 | 5.4% | $61.20 | -16.6% | COM | 632307104 |
| — | OUTSET MED INC | 1,200,385 | $26,252 | 4.9% | $24.80 | — | COM | 690145107 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 136,756 | $25,975 | 4.9% | $150.46 | +31.8% | COM | 02043Q107 |
| ARGX | ARGENX SE | 64,400 | $25,099 | 4.7% | $302.95 | — | SPONSORED ADR | 04016X101 |
| INSP | INSPIRE MED SYS INC | 72,843 | $23,648 | 4.4% | $208.73 | +36.9% | COM | 457730109 |
| LNTH | LANTHEUS HLDGS INC | 253,200 | $21,249 | 4.0% | $64.49 | +39.1% | COM | 516544103 |
| DXCM | DEXCOM INC | 162,400 | $20,870 | 3.9% | $92.70 | +30.5% | COM | 252131107 |
| — | CATALENT INC | 459,621 | $19,929 | 3.7% | $43.36 | — | COM | 148806102 |
| TMDX | TRANSMEDICS GROUP INC | 232,032 | $19,486 | 3.6% | $76.55 | 0.0% | COM | 89377M109 |
| GH | GUARDANT HEALTH INC | 445,161 | $15,937 | 3.0% | $37.08 | -22.5% | COM | 40131M109 |
| PRCT | PROCEPT BIOROBOTICS CORP | 337,218 | $11,921 | 2.2% | $34.93 | -5.3% | COM | 74276L105 |
| SRPT | SAREPTA THERAPEUTICS INC | 97,340 | $11,147 | 2.1% | $129.72 | -0.7% | COM | 803607100 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | 1,214,860 | $8,152 | 1.5% | $18.79 | -60.4% | COM | 00650F109 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 437,911 | $7,913 | 1.5% | $16.94 | +8.7% | COM | 35104E100 |
| TNDM | TANDEM DIABETES CARE INC | 320,325 | $7,861 | 1.5% | $48.45 | -33.6% | COM NEW | 875372203 |
| AGIO | AGIOS PHARMACEUTICALS INC | 267,630 | $7,579 | 1.4% | $38.79 | -35.9% | COM | 00847X104 |
| — | CANO HEALTH INC | 4,290,901 | $5,964 | 1.1% | $1.26 | — | COM CL A | 13781Y103 |
| — | FUSION PHARMACEUTICALS INC | 680,370 | $3,177 | 0.6% | $4.67 | — | COM | 36118A100 |
| — | AMERICAN WELL CORP | 1,395,039 | $2,930 | 0.5% | $6.68 | — | CL A | 03044L105 |
| — | POINT BIOPHARMA GLOBAL INC | 306,142 | $2,774 | 0.5% | $9.06 | — | COM | 730541109 |
| — | CAREMAX INC | 714,755 | $2,223 | 0.4% | $11.10 | — | COM CL A | 14171W103 |